Your session is about to expire
← Back to Search
Acceptance and Commitment Therapy for Postoperative Pain After Knee Replacement
Phase 2 & 3
Recruiting
Led By Barbara Rakel, PhD
Research Sponsored by Barbara A Rakel
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Scheduled for unilateral total knee arthroplasty (TKA)
scheduled for unilateral total knee arthroplasty (TKA)
Must not have
Bipolar or psychotic disorder
ACT therapy within the past year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (preop) to 6 months post-surgery
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether Acceptance and Commitment Therapy (ACT) is more effective than Attention Control (AC) in reducing postoperative pain and improving functioning in at-risk Veterans undergoing total knee arthroplasty (TKA).
Who is the study for?
This trial is for Veterans scheduled for knee replacement surgery who are 'at-risk' due to severe or moderate pain, anxiety, depression, or high levels of distress about pain. They must be able to complete study forms and attend a workshop before surgery. Those with bipolar/psychotic disorders, cognitive impairment, recent ACT therapy, or brain injury history cannot join.
What is being tested?
The trial tests if Acceptance and Commitment Therapy (ACT) is better than Attention Control (AC) at reducing post-surgery pain and improving functioning in Veterans after knee replacement. It also looks at the impact on anxiety, depression, coping skills over time up to 6 months post-surgery.
What are the potential side effects?
While not medication-based interventions that typically have side effects like drugs do, participants may experience emotional discomfort when engaging in therapy sessions as they confront personal issues related to their pain and recovery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a knee replacement surgery on one knee.
Select...
I am scheduled for a knee replacement surgery on one knee.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with bipolar or psychotic disorder.
Select...
I have not had ACT therapy in the last year.
Select...
I cannot attend the pre-surgery workshop.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (preop) to 6 months post-surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (preop) to 6 months post-surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Function
Pain Intensity
Secondary study objectives
Anxiety
Depressive Symptoms
Level of Pain Acceptance
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Acceptance and Commitment Therapy (ACT)Experimental Treatment1 Intervention
The ACT intervention will include: 1) Acceptance and Mindfulness Training emphasizing new ways of managing troubling thoughts, feelings, and physical sensations (e.g., learning how to recognize, and develop cognitive distance from, unhelpful thoughts such as "I can't take this pain anymore" or "This is unfair") and learning how to willingly face experiences that cannot be changed; and 2) Behavioral Change Training involving a) teaching patients how to recognize ineffective patterns of behavior and habits, b) exploring and setting life goals and goals related to mental and physical health, and c) promoting effective and committed actions to achieve these goals despite the urge to do otherwise. The workshop will also include information on pain and pain control post-TKA.
Group II: Attention Control (AC)Active Control1 Intervention
The primary purpose of this workshop is to provide attention and education to participants. Topics of discussion will include: a) the pathophysiology of postoperative pain and how it differs from preoperative pain, b) the role of contextual factors (e.g., depressive or anxiety symptoms, expectation) on the experience of pain, d) the role of inflammation in pain and healing, e) types of pain medications and other pain relief strategies provided following surgery, and f) goals of pain medications. Additionally, deep (diaphragmatic) breathing strategies will be taught and a progressive muscle relaxation exercise will be performed in the workshop at strategic times to maintain Veteran engagement.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acceptance and Committment Therapy (ACT)
2015
N/A
~100
Find a Location
Who is running the clinical trial?
Barbara A RakelLead Sponsor
2 Previous Clinical Trials
405 Total Patients Enrolled
Baylor College of MedicineOTHER
1,024 Previous Clinical Trials
6,029,080 Total Patients Enrolled
9 Trials studying Pain
1,780 Patients Enrolled for Pain
Barbara Rakel, PhDPrincipal InvestigatorUniversity of Iowa
2 Previous Clinical Trials
131 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am considered 'at-risk' due to my pain and mood symptoms.I have been diagnosed with bipolar or psychotic disorder.You have severe or moderate pain and show signs of anxiety or depression.You have trouble with memory or thinking, as determined by a test called the SLUMS exam.You have had a brain injury in the past.I am scheduled for a knee replacement surgery on one knee.I have not had ACT therapy in the last year.I am scheduled for a knee replacement surgery on one knee.I cannot attend the pre-surgery workshop.
Research Study Groups:
This trial has the following groups:- Group 1: Attention Control (AC)
- Group 2: Acceptance and Commitment Therapy (ACT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger